LAURA CROWLEY: Open Payments
NPI 1588128946 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,732 in 78 payments from 21 companies in 2025. Trend: 2023 $1,489 · 2024 $1,520 · 2025 $1,732
Food & beverage: $1,732
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $233 |
| Abbott Laboratories | 2 | $223 |
| United Therapeutics Corporation | 7 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $174 |
| Kestra Medical Technology Services, Inc. | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Merck Sharp & Dohme LLC | 3 | $95 |
| HEARTFLOW, INC. | 1 | $88 |
| BridgeBio Pharma, Inc. | 4 | $84 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
Products named: LEQVIO, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Tyvaso, Kerendia, Assure WCD, FFRct, Attruby, AMVUTTRA.
Industry payments across TN — which companies pay providers there.
